Experienced in Bowel Incontinence

Aiwen W. Wu

Key Laboratory Of Carcinogenesis And Translational Research, 
Beijing, CN 
Experienced in Bowel Incontinence
Key Laboratory Of Carcinogenesis And Translational Research, 
Beijing, CN 
OverviewLocationsClinical Research

Overview

Aiwen Wu practices in Beijing, China. Wu is rated as an Experienced expert by MediFind in the treatment of Bowel Incontinence. Their top areas of expertise are Colorectal Cancer, Stomach Cancer, Turcot Syndrome, Lymphadenectomy, and Gastrectomy.

Their clinical research consists of co-authoring 125 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Bowel Incontinence.

Locations

Key Laboratory Of Carcinogenesis And Translational Research, Beijing, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Tailored Operative or Non-operative Management for MRI Defined Low-risk Rectal Cancer Following Neoadjuvant Intensity Modulated Radiotherapy With Concurrent Capecitabine Plus Consolidation CapeOX.
Tailored Operative or Non-operative Management for MRI Defined Low-risk Rectal Cancer Following Neoadjuvant Intensity Modulated Radiotherapy With Concurrent Capecitabine Plus Consolidation CapeOX.
Enrollment Status: Completed
Publish Date: July 23, 2021
Intervention Type: Radiation, Procedure, Behavioral, Drug
Total Neoadjuvant Induction and Consolidation CapeOX Plus Neoadjuvant Intensity Modulated Radiotherapy With Concurrent Capecitabine for MRI Defined High-risk Rectal Cancer
Total Neoadjuvant Induction and Consolidation CapeOX Plus Neoadjuvant Intensity Modulated Radiotherapy With Concurrent Capecitabine for MRI Defined High-risk Rectal Cancer
Enrollment Status: Completed
Publish Date: July 23, 2021
Intervention Type: Procedure, Drug, Radiation
Study Phase: Phase 2
View 1 Less Clinical Trial

125 Total Publications

Immune checkpoint inhibitor-related gastrointestinal adverse events: a disproportionality analysis based on the FAERS database.
Immune checkpoint inhibitor-related gastrointestinal adverse events: a disproportionality analysis based on the FAERS database.
Journal: Expert opinion on drug safety
Published: October 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Wu's expertise for a condition
ConditionClose
    View All 10 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile